Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
TherapeuticsMD (TXMD)
NASDAQ:TXMD
Holding TXMD?
Track your performance easily
TXMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.70 - $2.75
Previous CloseN/A
Volume92.69K
Average Volume (3M)585.19K
Market Cap
$11.99M
Enterprise Value$21.50M
Total Cash (Recent Filing)$131.53M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.42
Next Earnings
Feb 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.29
Shares Outstanding11,532,432
10 Day Avg. Volume910,379
30 Day Avg. Volume585,193
Standard Deviation0.23
R-Squared0.07
Alpha-0.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)28.49
Price to Cash Flow (P/CF)-160.10
P/FCF Ratio0.00
Enterprise Value/Market Cap1.79
Enterprise Value/Revenue20.65
Enterprise Value/Gross Profit16.51
Enterprise Value/Ebitda-4.28
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
TherapeuticsMD News
PremiumCompany Announcements
TherapeuticsMD Reports Reduced Losses Amid Strategic ShiftPremiumCompany Announcements
TherapeuticsMD Shifts Focus with Lower Q3 Losses
PremiumCompany Announcements
TherapeuticsMD Releases Preliminary Quarterly Financial Results
PremiumCompany Announcements
TherapeuticsMD Releases Preliminary Q1 2024 Financials
PremiumCompany Announcements
TherapeuticsMD Announces 2023 Annual Financial Results
Options Prices
Currently, No data available
---
Ownership Overview
0.45% Insiders
4.57% Mutual Funds
<0.01% Other Institutional Investors
91.75% Public Companies and Individual Investors
TXMD FAQ
What was TherapeuticsMD’s price range in the past 12 months?
TherapeuticsMD lowest stock price was $0.70 and its highest was $2.75 in the past 12 months.
What is TherapeuticsMD’s market cap?
TherapeuticsMD’s market cap is $11.99M.
When is TherapeuticsMD’s upcoming earnings report date?
TherapeuticsMD’s upcoming earnings report date is Feb 20, 2025 which is in 33 days.
How were TherapeuticsMD’s earnings last quarter?
TherapeuticsMD released its earnings results on Nov 12, 2024. The company reported -$0.05 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.05.
Is TherapeuticsMD overvalued?
According to Wall Street analysts TherapeuticsMD’s price is currently Overvalued.
Does TherapeuticsMD pay dividends?
TherapeuticsMD does not currently pay dividends.
What is TherapeuticsMD’s EPS estimate?
TherapeuticsMD’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TherapeuticsMD have?
TherapeuticsMD has 11,532,432 shares outstanding.
What happened to TherapeuticsMD’s price movement after its last earnings report?
TherapeuticsMD reported an EPS of -$0.05 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of TherapeuticsMD?
Currently, no hedge funds are holding shares in TXMD
---
Company Description
TherapeuticsMD
TherapeuticsMD, Inc. is a pharmaceutical company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The firm also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.
---
Technical Analysis
ANI Pharmaceuticals
―
Evofem Biosciences
―
Verrica Pharmaceuticals
―
Eton Pharmaceuticals
―
SELLAS Life Sciences Group
―
---